Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Harriët H. Blaauwgeers"'
Autor:
Irène Philip, Francesco Monetti, Femke Boomsma, Dominique de Valeriola, Marek Svoboda, Gordon McVie, Sebastian Kehrloesser, Mahasti Saghatchian, Wim H. van Harten, Thierry Philip, Péter Nagy, Paolo De Paoli, Anke Wind, Gunnar Sæter, József Lövey, Marjet M. Docter, Harriët H. Blaauwgeers, Willien Westerhuis, Jean Benoit Burrion, Eva Gustafsson, Claudio Lombardo, Astrid Wendler, Henk Hummel, Simon Oberst, Renée Otter
Publikováno v:
Molecular oncology, 15(5), 1277-1288. Elsevier
Molecular Oncology
Molecular Oncology, Vol 15, Iss 5, Pp 1277-1288 (2021)
Molecular Oncology
Molecular Oncology, Vol 15, Iss 5, Pp 1277-1288 (2021)
There is a persistent variation in cancer outcomes among and within European countries suggesting (among other causes) inequalities in access to or delivery of high‐quality cancer care. European policy (EU Cancer Mission and Europe’s Beating Canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fd7fc0078e4ec240145e61b12d90f0f
https://research.utwente.nl/en/publications/a33dcc93-c3bd-48d0-910f-aa3a33e0e853
https://research.utwente.nl/en/publications/a33dcc93-c3bd-48d0-910f-aa3a33e0e853
Autor:
Dominique de Valeriola, Simon Oberst, Femke Boomsma, Angelo Paradiso, Marjet M. Docter, Paolo P. De Paoli, Mahasti Saghatchian, Harriët H. Blaauwgeers, Claudio Lombardo
Publikováno v:
Tumori Journal. 101:S6-S9
The Organisation of European Cancer Institutes (OECI) launched a program for accreditation and designation (A&D) of cancer centers in Europe based on voluntary participation in 2008. In 2012, the Italian Ministry of Health decided to fund cancer cent
Autor:
Kehrloesser S; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, UK., Oberst S; Organisation of European Cancer Institutes, Brussels, Belgium.; Cancer Research UK Cambridge Centre, University of Cambridge, UK., Westerhuis W; the Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., Wendler A; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, UK., Wind A; Rijnstate Hospital, Arnhem, The Netherlands., Blaauwgeers H; the Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., Burrion JB; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Nagy P; National Institute of Oncology, Budapest, Hungary., Saeter G; Organisation of European Cancer Institutes, Brussels, Belgium.; Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Gustafsson E; Theme Cancer, Karolinska University Hospital, Stockholm, Sweden., De Paoli P; Alliance Against Cancer, Rome, Italy., Lovey J; Organisation of European Cancer Institutes, Brussels, Belgium.; National Institute of Oncology, Budapest, Hungary., Lombardo C; Organisation of European Cancer Institutes, Brussels, Belgium., Philip T; Organisation of European Cancer Institutes, Brussels, Belgium.; Institut Curie, Paris Cedex 05, France., de Valeriola D; Organisation of European Cancer Institutes, Brussels, Belgium.; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Docter M; Rijnstate Hospital, Arnhem, The Netherlands., Boomsma F; Radiotherapeutisch Instituut Friesland, Leeuwarden, The Netherlands., Saghatchian M; Institut Gustave Roussy, Villejuif, France.; American Hospital of Paris, Neuilly-sur-Seine, France., Svoboda M; Masaryk Memorial Cancer Institute, Brno, Czech Republic., Philip I; Centre Léon Bérard, Lyon, France., Monetti F; Ospedale Policlinico San Martino, Genova, Italy., Hummel H; the Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., McVie G; Cancer Intelligence, Bristol, UK., Otter R, van Harten W; Organisation of European Cancer Institutes, Brussels, Belgium.; Rijnstate Hospital, Arnhem, The Netherlands.; The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Health Technology and Services Research, University of Twente, Enschede, The Netherlands.
Publikováno v:
Molecular oncology [Mol Oncol] 2021 May; Vol. 15 (5), pp. 1277-1288. Date of Electronic Publication: 2021 Mar 30.
Autor:
Oberst S; Cambridge Cancer Centre, Cambridge - UK., Boomsma F; The Netherlands Comprehensive Cancer Organisation (IKNL) - The Netherlands., Lombardo C; Organization of European Cancer Institutes, Bruxelles - Belgium.; SOS Europe Srl, Genova - Italy., Docter M; The Netherlands Comprehensive Cancer Organisation (IKNL) - The Netherlands., Blaauwgeers H; The Netherlands Comprehensive Cancer Organisation (IKNL) - The Netherlands., De Paoli P; Scientific Directorate, Centro di Riferimento Oncologico (CRO), IRCCS, National Cancer Institute, Aviano (Pordenone) - Italy., de Valeriola D; Institut Jules Bordet, Université Libre de Bruxelles, Bruxelles - Belgium., Paradiso A; Experimental Medical Oncology, Istituto Tumori G. Paolo II, IRCCS, National Cancer Institute, Bari - Italy., Saghatchian M; Medical Oncology Department, Institut Gustave Roussy, Villejuif - France.
Publikováno v:
Tumori [Tumori] 2015; Vol. 101 Suppl 1, pp. S6-9. Date of Electronic Publication: 2015 Dec 30.